Pharma Blog Watch


New T-Cell Lymphoma Treatment (The Pharm Voice)
In her entry, blogger Gloria Gamat discusses Favrille's electronic investigational new drug (IND) application for FAV-201, a patient-specific immunotherapy for the treatment of T-cell lymphoma.

Zocor Goes Off-Patent (Patent Baristas)
Blogger Karlyn Schnapp discusses the issues faced by Merck as its cholesterol medication Zocor going off-patent.